Two Sigma Securities, LLC Alterity Therapeutics LTD Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.01 - $4.8 $231 - $111,312	23,190 New	23,190 $10,000
Q2 2022 Aug 15, 2022	SELL	$0.01 - $0.02 $102 - $204	-10,206 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.01 - $0.02 $99 - $198	-9,945 Reduced 49.35%	10,206 $8,000
Q4 2021 Feb 14, 2022	BUY	$0.01 - $0.02 $40 - $80	4,044 Added 25.11%	20,151 $15,000
Q3 2021 Nov 15, 2021	BUY	$0.02 - $0.03 $322 - $483	16,107 New	16,107 $20,000

Ticker ATHE
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,114,600
Market Cap $59.4M
Description
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.